GoHealth (GOCO)
(Delayed Data from NSDQ)
$10.15 USD
+0.14 (1.40%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $10.15 0.00 (0.00%) 7:58 PM ET
5-Strong Sell of 5 5
D Value B Growth A Momentum B VGM
Income Statements
Fiscal Year end for GoHealth, Inc falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 735 | 632 | 1,062 | 877 | 540 |
Cost Of Goods | 159 | 188 | 239 | 199 | 170 |
Gross Profit | 576 | 444 | 823 | 678 | 370 |
Selling & Adminstrative & Depr. & Amort Expenses | 657 | 763 | 1,313 | 743 | 403 |
Income After Depreciation & Amortization | -82 | -319 | -489 | -65 | -33 |
Non-Operating Income | 0 | 0 | -11 | 0 | 0 |
Interest Expense | 69 | 57 | 34 | 33 | 8 |
Pretax Income | -151 | -376 | -534 | -97 | -41 |
Income Taxes | 0 | 1 | 0 | 0 | 0 |
Minority Interest | -88 | -228 | -345 | -53 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | -151 | -376 | -534 | -97 | -41 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | -63 | -149 | -189 | -44 | -41 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 37 | -209 | 7 | 36 | 1 |
Depreciation & Amortization (Cash Flow) | 119 | 110 | 496 | 101 | 33 |
Income After Depreciation & Amortization | -82 | -319 | -489 | -65 | -33 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 9.29 | 8.45 | 7.07 | 5.62 | NA |
Diluted EPS Before Non-Recurring Items | -5.95 | -14.76 | 17.69 | 37.63 | NA |
Diluted Net EPS (GAAP) | -7.19 | -17.72 | -26.84 | -3.30 | NA |
Fiscal Year end for GoHealth, Inc falls in the month of December .
All items in Millions except EPS data.
3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 | |
---|---|---|---|---|---|
Sales | NA | 276.70 | 132.04 | 142.78 | 183.16 |
Cost Of Goods | NA | 41.09 | 35.99 | 36.42 | 45.46 |
Gross Profit | NA | 235.61 | 96.05 | 106.36 | 137.70 |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 220.55 | 134.02 | 159.38 | 143.44 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | 15.06 | -37.97 | -53.02 | -5.74 |
Non-Operating Income | NA | 0.78 | -0.77 | -0.02 | 0.05 |
Interest Expense | NA | 17.75 | 17.57 | 17.27 | 16.89 |
Pretax Income | NA | -1.91 | -56.31 | -70.30 | -22.59 |
Income Taxes | NA | 0.38 | -0.11 | -0.07 | -0.04 |
Minority Interest | NA | -1.07 | -32.29 | -41.29 | -13.36 |
Investment Gains/Losses | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | NA | -2.29 | -56.20 | -70.23 | -22.54 |
Extras & Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | NA | -1.23 | -23.91 | -28.94 | -9.18 |
Earnings Per Share Data | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 |
---|---|---|---|---|---|
Average Shares | NA | 9.58 | 9.49 | 9.12 | 8.97 |
Diluted EPS Before Non-Recurring Items | NA | 0.60 | -2.61 | -1.77 | -1.12 |
Diluted Net EPS (GAAP) | NA | -0.19 | -2.61 | -3.27 | -1.12 |